repeated appointments, and periods of temporary improvement followed by painful setbacks.
The executive order seeks to accelerate research and regulatory review for therapies that have already received special designations because of their potential to address serious medical conditions.
Rather than immediately approving psychedelic treatments for widespread continue reading …